Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Methacrylic Acid Ethyl Acrylate Copolymer Aqueous Dispersion sits at the intersection of chemistry and pharmaceutical utility, offering a robust solution for coating and controlled-release systems. This compound forms through the copolymerization of methacrylic acid and ethyl acrylate, producing a substance that answers the relentless demand for reliable excipients in drug formulation. The pharmaceutical grade version adheres to pharmacopeial standards, marked BP, EP, and USP, ensuring consistency batch to batch and proving its worth for regulated industries.
Manufacturers harness this copolymer to craft film coatings for tablets and capsules, prioritizing modified-release and enteric features. Pharmacies turn to these dispersions for precise barrier properties that hold up against digestive fluids, spacing the release of actives until the optimal site within the body. Experience shows that reliable enteric coatings can mean the difference between therapeutic effectiveness and wasted product. The polymer comes as an aqueous dispersion, usually milky white, but the processed end forms range widely—solid flakes, powders, pearls, or even concentrated solutions, letting formulation scientists choose what fits their process.
The copolymer consists of repeating units of methacrylic acid and ethyl acrylate, typically in a 1:1 ratio. The backbone carries carboxylic groups lending it pH-responsive qualities. This structure translates to the desirable property: resistance to dissolution in acidic environments, breaking down in the mildly alkaline pH of the intestine. Molecular formula runs to (C10H14O4)n, reflecting the repeating nature of the polymer. The material’s density sits around 1.18–1.23 g/cm3. These metrics give formulators a shorthand for predicting how it will behave in processing and in the finished pharmaceutical.
Pharmaceutical grade standards mandate a high bar. Purity—often above 99% by dried substance—minimizes the risk of unwanted reactions. Particle size distribution follows tight controls to secure consistent coverage in coatings, usually with D90 under 20 microns for powder and under 1 micron for dispersions. Solid content in the liquid dispersion typically hits 30%, meaning one liter contains about 300 grams of polymer, simplifying scaling calculations. pH value for a 10% solution lands between 2.0 and 3.0. Viscosity, another key parameter, maintains a range fit for current coating equipment—neither clogging nor running off.
Customs and compliance professionals rely on the HS Code 390690 for "Acrylic polymers in primary forms, others" to ensure smooth international shipments. QA departments appreciate the uniform adoption of BP, EP, and USP standards, easing document burdens during audits and submissions. Certificates of analysis cover elemental impurities, residual monomers, heavy metals, and microbial contamination, reducing risk to end users and protecting patient safety.
Practitioners in drug development regularly handle the copolymer in several physical states. As solid flakes, it stores well, with low sensitivity to moisture and stable shelf life. Processing lines may favor powders for quick dispersion or pearls for lower dust generation. In its aqueous dispersion, the substance comes ready for use in pan and fluid-bed coaters, safeguarding workers from inhalation exposure and cutting down cleaning routines. The liquid form, once adjusted, allows for direct use in high-speed pharmaceutical manufacturing, a clear advantage when every minute counts.
The copolymer carries the usual chemical caution labels. While non-toxic in finished pharmaceutical use, bulk material presents mild hazard: avoid inhalation or contact with eyes. Proper PPE—gloves, goggles, and dust masks—keep workers safe. It does not support microbial growth, reducing bioburden risks, though it requires storage in clean, sealed containers, away from heat and oxidizing agents. Waste from production or cleaning heads to chemical recycling channels designed for polymers. The main raw materials—methacrylic acid and ethyl acrylate—both have established safety profiles, but only reputable suppliers with transparent sourcing can support GMP production. This focus on upstream quality saves months of headaches downstream.
Once dispersed, these polymers present as colloidal particles, stable thanks to the negative charge from carboxylic acid groups. In water, the copolymer neither settles rapidly nor forms large aggregates, which matters for uniform coating and smooth flow through pipes and spray nozzles. Under the right conditions, the solution shifts from fluid to film as water evaporates during processing, forming the tight barriers that keep drugs protected inside tablets. This transition, from mobile dispersion to solid coating, may seem minor, but it marks the leap from chemistry to patient benefit.
Years in regulated industry have shown that quality in excipients means fewer recalls and better patient adherence. Methacrylic acid ethyl acrylate copolymer dispersions, kept under continuous improvement, speak to the lessons learned from past failures—stamp out contaminants, keep spec sheets honest, and practice radical transparency. Document control, robust supply chain audits, and responsive customer support count most when a batch goes off spec or a regulator drops by unannounced. A product meeting BP, EP, and USP standards offers certainty that every batch works as intended: safe, consistent, and true to label, lining up with responsible pharma’s core mission.
Chengguan District, Lanzhou, Gansu, China
